Nephrology Doctors in East Meadow, NY Accepting Medicare

5 Nephrology doctors found. Showing 1 - 5

Dr. Robert R Purvin, D.O. Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 1757 Front St, East Meadow, NY 11554 Phone: 516-967-2829    Fax: 516-489-6861

Dr. Dona Tsihwa Wu, M.D. / P.H.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1620 Front St, East Meadow, NY 11554 Phone: 516-514-0105    Fax: 516-706-5849

Dr. Zae Kim, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2201 Hempstead Tpke, Department Of Medicine, East Meadow, NY 11554 Phone: 516-572-1800

Swetha Makkapati, Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2201 Hempstead Tpke, East Meadow, NY 11554 Phone: 516-572-6301

Dr. Laurie Ward, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2201 Hempstead Tpke, East Meadow, NY 11554 Phone: 516-572-5878

News Archive

Unhealthy gut microbiome reduces brain synaptic pruning, impairs learning

A new study by Weill Cornell Medicine and Cornell University has come up with more explanations of how gut microbes communicate with the brain neurons. The study, published in the journal Nature on October 23, 2019, examined the brains of mouse models and found that when the gut microbiome is significantly reduced, there are changes in gene expression in the brain's microglial cells.

Study identifies effective market research approaches to understand payer needs, decision-making

The Affordable Care Act has been the catalyst for dramatic change in US healthcare. The power structures that influence this $2.8 trillion economic sector are shifting, but one thing is crystal clear: A large percentage of the pharmaceutical sector's top-line revenues flow from payers.

Akela Pharma first-quarter net loss reduces to $0.4 million

Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today announced its financial results for the three months ended March 31, 2010.

Study provides insights into how cancer cells can evade FGFR inhibitors

A new study by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute has identified a mechanism by which cancer cells develop resistance to a class of drugs called fibroblast growth factor receptor (FGFR) inhibitors.

Read more Medical News

› Verified 8 days ago